Yang Arvin 4
4 · Mersana Therapeutics, Inc. · Filed Jan 19, 2022
Insider Transaction Report
Form 4
Yang Arvin
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2022-01-14+28,333→ 28,333 total→ Common Stock (28,333 underlying) - Award
Stock Option (right to buy)
2022-01-14+127,500→ 127,500 totalExercise: $6.28Exp: 2032-01-13→ Common Stock (127,500 underlying)
Holdings
- 12,973
Common Stock
Footnotes (3)
- [F1]The option vests in equal quarterly installments over the first four years after the vesting commencement date, January 14, 2022.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 14, 2022.